DEA's Case For Scheduling Psychedelics Challenged In Landmark Hearing
Javier Gasse
Thu, Nov 21
A DEA legal battle over the scheduling of DOI and DOC as Schedule I substances could severely impact psychedelic research.
Share your feedback with us
If you're passionate about plant medicine and excited by our mission, we'd love to hear your perspective on how we can best meet your needs.
Share Feedback Join our waitlist
Join our waitlist today to get ahead of the curve and become a part of this trailblazing community.
Join Today Share with friends
Invite your friends to be part of this trailblazing community revolutionizing mental health, physical wellbeing, and human consciousness.